Clinical Trial Update: Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

View source ↗

Summary

A real-world, patient-reported outcome study of Sacituzumab Govitecan in Chinese patients with metastatic triple-negative breast cancer; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Fudan University | Conditions: TNBC - Triple-Negative Breast Cancer | Status: RECRUITING